Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Segment Analysis By Drug: Ozempic Dominance Faces Dual-Agonist Challenge The GLP-1 diabetes drugs market size for brand-level competition shows Ozempic at USD 11.36 billion revenue in 2025, translating to a 31.88% GLP-1 diabetes drugs market share
However, the quality and safety of these compounded drugs can vary
Another relevant emerging concept is engineering cells to secrete enzymes in response to triggers, ranging from biomaterial to molecular or cellular signals
Obesity and osteoarthritis
)
US$ 26.06
US$ 26.05
US$ 21.09
US$ 27.59
US$ 27.23
US$ 27.24
